Eli Lilly

Eli Lilly, incorporated in 1876, is headquartered in Indianapolis, Indiana, United States. The company operates in various business segments, focusing on the development and selling of pharmaceutical products. Its most important business categories include Endocrinology, which covers diabetes care products like insulin; Oncology, dedicated to cancer treatment medications; Immunology for treatments addressing autoimmune diseases; Neuroscience, targeting psychiatric conditions; along with a range of Other Pharmaceuticals. Among its most recognized brands are Humalog, an insulin lispro for diabetes care; Cialis, known as tadalafil for erectile dysfunction; Alimta, or pemetrexed, which is used in cancer treatment; Forteo, the brand name for teriparatide used in osteoporosis treatment; Trulicity, or dulaglutide, another diabetes medication; Taltz, with its active agent ixekizumab for autoimmune diseases; the migraine treatment Emgality, or galcanezumab; and Olumiant, known as baricitinib, for rheumatoid arthritis. Eli Lilly's global presence is marked by the sale of its products and services in multiple countries. The company has a widespread market across various continents, notably including but not limited to the United States, European nations, China, Japan, Canada, Australia, and extends to emerging markets in Asia, Latin America, and Africa. (Powered by AI)